Alastair Garfield - Chief Scientific Officer at RHYTHM PHARMACEUTICALS, INC.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Scientific Officer
Issuer Symbol
RYTM on Nasdaq
All Insider Reports
All Insider Reports

Alastair Garfield - trading volume in the past year for RHYTHM PHARMACEUTICALS, INC.

Holdings reported by Alastair Garfield for RHYTHM PHARMACEUTICALS, INC.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 16,650 $1,524,913 $57.22 11 Feb 2026 Direct Common Stock
Common Stock 7,763 $846,089 $108.99 01 Feb 2026 Direct
Stock Options (Right to Buy) 25,000 11 Feb 2026 Direct Common Stock

Transactions reported by Alastair Garfield for RHYTHM PHARMACEUTICALS, INC.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.